MHC class II (MHCII) molecules play a pivotal role in the induction and regulation of immune responses. The transcriptional coactivator class II transactivator (CIITA) controls MHCII expression. The CIITA gene is regulated by three independent promoters (pI, pIII, pIV). We have generated pIV knockout mice. These mice exhibit selective abrogation of interferon (IFN)-γ–induced MHCII expression on a wide variety of non-bone marrow–derived cells, including endothelia, epithelia, astrocytes, and fibroblasts. Constitutive MHCII expression on cortical thymic epithelial cells, and thus positive selection of CD4+ T cells, is also abolished. In contrast, constitutive and inducible MHCII expression is unaffected on professional antigen-presenting cells, including B cells, dendritic cells, and IFN-γ–activated cells of the macrophage lineage. pIV−/− mice have thus allowed precise definition of CIITA pIV usage in vivo. Moreover, they represent a unique animal model for studying the significance and contribution of MHCII-mediated antigen presentation by nonprofessional antigen-presenting cells in health and disease.
Skip Nav Destination
Article navigation
20 August 2001
Article|
August 13 2001
Selective Abrogation of Major Histocompatibility Complex Class II Expression on Extrahematopoietic Cells in Mice Lacking Promoter IV of the Class II Transactivator Gene
Jean-Marc Waldburger,
Jean-Marc Waldburger
aDepartment of Genetics and Microbiology, University of Geneva Medical School, 1211 Geneva 4, Switzerland
Search for other works by this author on:
Tobias Suter,
Tobias Suter
bSection of Clinical Immunology, University Hospital, 8044 Zurich, Switzerland
Search for other works by this author on:
Adriano Fontana,
Adriano Fontana
bSection of Clinical Immunology, University Hospital, 8044 Zurich, Switzerland
Search for other works by this author on:
Hans Acha-Orbea,
Hans Acha-Orbea
cLudwig Institute for Cancer Research, Lausanne Branch, and Institute of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland
Search for other works by this author on:
Walter Reith
Walter Reith
aDepartment of Genetics and Microbiology, University of Geneva Medical School, 1211 Geneva 4, Switzerland
Search for other works by this author on:
Jean-Marc Waldburger
aDepartment of Genetics and Microbiology, University of Geneva Medical School, 1211 Geneva 4, Switzerland
Tobias Suter
bSection of Clinical Immunology, University Hospital, 8044 Zurich, Switzerland
Adriano Fontana
bSection of Clinical Immunology, University Hospital, 8044 Zurich, Switzerland
Hans Acha-Orbea
cLudwig Institute for Cancer Research, Lausanne Branch, and Institute of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland
Walter Reith
aDepartment of Genetics and Microbiology, University of Geneva Medical School, 1211 Geneva 4, Switzerland
H. Acha-Orbea and W. Reith contributed equally to this work.
Abbreviations used in this paper: CIITA, class II transactivator; CNS, central nervous system; cTECs, cortical thymic epithelial cells; DCs, dendritic cells; ES, embryonic stem; MEFs, mouse embryonic fibroblasts; MHCI, MHC class I; MHCII, MHC class II.
Received:
January 16 2001
Revision Requested:
April 12 2001
Accepted:
May 21 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 194 (4): 393–406.
Article history
Received:
January 16 2001
Revision Requested:
April 12 2001
Accepted:
May 21 2001
Citation
Jean-Marc Waldburger, Tobias Suter, Adriano Fontana, Hans Acha-Orbea, Walter Reith; Selective Abrogation of Major Histocompatibility Complex Class II Expression on Extrahematopoietic Cells in Mice Lacking Promoter IV of the Class II Transactivator Gene. J Exp Med 20 August 2001; 194 (4): 393–406. doi: https://doi.org/10.1084/jem.194.4.393
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement